FDAFDA · Food and drugs·Recall number D-0418-2026
Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.
Published April 1, 2026 · Recall initiated: March 16, 2026
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed tablet specifications.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- MECLIZINE HYDROCHLORIDE
- Manufacturer
- Amerisource Health Services LLC
- Distributor
- U.S. Nationwide
- Lot
- Lot #1024852; Exp 9/30/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.